These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 31098749)

  • 1. Clinical and dosimetric considerations for Y90: recommendations from an international multidisciplinary working group.
    Salem R; Padia SA; Lam M; Bell J; Chiesa C; Fowers K; Hamilton B; Herman J; Kappadath SC; Leung T; Portelance L; Sze D; Garin E
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(8):1695-1704. PubMed ID: 31098749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical, dosimetric, and reporting considerations for Y-90 glass microspheres in hepatocellular carcinoma: updated 2022 recommendations from an international multidisciplinary working group.
    Salem R; Padia SA; Lam M; Chiesa C; Haste P; Sangro B; Toskich B; Fowers K; Herman JM; Kappadath SC; Leung T; Sze DY; Kim E; Garin E
    Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):328-343. PubMed ID: 36114872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yttrium-90 Selective Internal Radiation Therapy with Glass Microspheres for Hepatocellular Carcinoma: Current and Updated Literature Review.
    Lee EW; Alanis L; Cho SK; Saab S
    Korean J Radiol; 2016; 17(4):472-88. PubMed ID: 27390539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dosimetric treatment planning strategy in radioembolization of hepatocarcinoma with 90Y glass microspheres.
    Chiesa C; Mira M; Maccauro M; Romito R; Spreafico C; Sposito C; Bhoori S; Morosi C; Pellizzari S; Negri A; Civelli E; Lanocita R; Camerini T; Bampo C; Carrara M; Seregni E; Marchianò A; Mazzaferro V; Bombardieri E
    Q J Nucl Med Mol Imaging; 2012 Dec; 56(6):503-8. PubMed ID: 23358402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient Selection and Clinical Outcomes of Y90 in Hepatocellular Carcinoma.
    Wehrenberg-Klee E; Gandhi RT; Ganguli S
    Tech Vasc Interv Radiol; 2019 Jun; 22(2):70-73. PubMed ID: 31079713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yttrium-90 microspheres (TheraSphere and SIR-Spheres) for the treatment of unresectable hepatocellular carcinoma.
    Allison C
    Issues Emerg Health Technol; 2007 Sep; (102):1-6. PubMed ID: 17824141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium.
    Kennedy A; Nag S; Salem R; Murthy R; McEwan AJ; Nutting C; Benson A; Espat J; Bilbao JI; Sharma RA; Thomas JP; Coldwell D
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):13-23. PubMed ID: 17448867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technical Aspects and Practical Approach Toward Same-Day Y90 Radioembolization in the Management of Hepatocellular Carcinoma.
    Gabr A; Ali R; Al Asadi A; Mora R; Mouli S; Riaz A; Salem R; Lewandowski RJ
    Tech Vasc Interv Radiol; 2019 Jun; 22(2):93-99. PubMed ID: 31079717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: Technical and methodologic considerations.
    Salem R; Thurston KG
    J Vasc Interv Radiol; 2006 Aug; 17(8):1251-78. PubMed ID: 16923973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calculation of tumour and normal tissue biological effective dose in
    Gallio E; Richetta E; Finessi M; Stasi M; Pellerito RE; Bisi G; Ropolo R
    Phys Med; 2016 Dec; 32(12):1738-1744. PubMed ID: 27876284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic arterial yttrium 90 microspheres: another treatment option for hepatocellular carcinoma.
    Dawson LA
    J Vasc Interv Radiol; 2005 Feb; 16(2 Pt 1):161-4. PubMed ID: 15713916
    [No Abstract]   [Full Text] [Related]  

  • 12. Development of activity standard for 90 Y microspheres.
    Mo L; Avci B; James D; Simpson B; Van Wyngaardt WM; Cessna JT; Baldock C;
    Appl Radiat Isot; 2005 Aug; 63(2):193-9. PubMed ID: 15963429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical impact of (99m)Tc-MAA SPECT/CT-based dosimetry in the radioembolization of liver malignancies with (90)Y-loaded microspheres.
    Garin E; Rolland Y; Laffont S; Edeline J
    Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):559-75. PubMed ID: 26338177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation Segmentectomy and Radiation Lobectomy: A Practical Review of Techniques.
    Malhotra A; Liu DM; Talenfeld AD
    Tech Vasc Interv Radiol; 2019 Jun; 22(2):49-57. PubMed ID: 31079710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yttrium-90 microspheres for the treatment of hepatocellular carcinoma: a review.
    Salem R; Hunter RD
    Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S83-8. PubMed ID: 16979447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioembolization of hepatocarcinoma with (90)Y glass microspheres: development of an individualized treatment planning strategy based on dosimetry and radiobiology.
    Chiesa C; Mira M; Maccauro M; Spreafico C; Romito R; Morosi C; Camerini T; Carrara M; Pellizzari S; Negri A; Aliberti G; Sposito C; Bhoori S; Facciorusso A; Civelli E; Lanocita R; Padovano B; Migliorisi M; De Nile MC; Seregni E; Marchianò A; Crippa F; Mazzaferro V
    Eur J Nucl Med Mol Imaging; 2015 Oct; 42(11):1718-1738. PubMed ID: 26112387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A computational tool for patient specific dosimetry and radiobiological modeling of selective internal radiation therapy with (90)Y microspheres.
    Kalantzis G; Leventouri T; Apte A; Shang C
    Appl Radiat Isot; 2015 Nov; 105():123-129. PubMed ID: 26296058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yttrium 90 microspheres for the treatment of hepatocellular carcinoma.
    Memon K; Lewandowski RJ; Riaz A; Salem R
    Recent Results Cancer Res; 2013; 190():207-24. PubMed ID: 22941023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resin Versus Glass Microspheres for
    Van Der Gucht A; Jreige M; Denys A; Blanc-Durand P; Boubaker A; Pomoni A; Mitsakis P; Silva-Monteiro M; Gnesin S; Lalonde MN; Duran R; Prior JO; Schaefer N
    J Nucl Med; 2017 Aug; 58(8):1334-1340. PubMed ID: 28082436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yttrium-90 radioembolization using TheraSphere in the management of primary and secondary liver tumors.
    Riaz A; Lewandowski RJ; Kulik L; Salem R
    Q J Nucl Med Mol Imaging; 2009 Jun; 53(3):311-6. PubMed ID: 19521310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.